Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-3032b monotherapy in MDM2-amplified intimal sarcoma (MADAME PRINCESA)
jRCT2091220402Completed
- Sponsor
- National Cancer Center Hospital
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of milademetan in intimal sarcoma, sponsored by National Cancer Center Hospital. Primary endpoint: Objective response (central review). Started Dec 2018; status: completed.
02
Drugs
milademetan
03
Conditions
intimal sarcoma
Beyond the preview
Go deeper on jRCT2091220402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220402.